SEATTLE, May 16, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced that the Company presented data demonstrating the potential of its RNAfix ...

Anthony Bolante | PSBJ By Rick Morgan – Inno Senior Reporter, Puget Sound Business Journal Oct 22, 2024 Preview this article 1 min ...

SEATTLE, April 28, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced the acceptance of multiple abstracts, including two oral presentations, at the ...

SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader at the convergence of AI and RNA editing to revolutionize genomic medicine, today announced its upcoming oral presentations ...

News provided by Shape Therapeutics, Inc. Oct 03, 2024, 1:05 PM ET Company's DeepREAD AI model and small RNA expression system represent major leaps forward in RNA editing efficiency and ...

Crispr Therapeutics: CASGEVY Commercial Launch Is Taking Shape Mar. 26, 2024 2:33 AM ET CRISPR Therapeutics AG (CRSP) Stock VRTX, CRSP 3 Comments 6 Likes SL Investments 3.17K Follower s ...

Industry-leading RNA editing activity in the CNS of both mice and non-human primates highlights the broad applicability and therapeutic potential of the RNAfix ® platform in CNS diseases ...